Method for producing a vaccine for the treatment of cancer

Details for Australian Patent Application No. 2006204896 (hide)

Owner Avax Technologies, Inc.

Inventors Berd, David

Agent Freehills

Pub. Number AU-A-2006204896

PCT Pub. Number WO2006/076508

Priority 60/696,951 06.07.05 US; 60/644,364 14.01.05 US

Filing date 13 January 2006

Wipo publication date 20 July 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076508 Priority application(s): WO2006/076508

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204907-Mycobacterial mutants affecting host apoptosis

2006204890-Point-of-sale investment systems